Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Severe consequences of a high-lipid diet include hydrogen sulfide dysfunction and enhanced aggression in glioblastoma
Daniel J. Silver, … , Christopher Hine, Justin D. Lathia
Daniel J. Silver, … , Christopher Hine, Justin D. Lathia
Published July 13, 2021
Citation Information: J Clin Invest. 2021;131(17):e138276. https://doi.org/10.1172/JCI138276.
View: Text | PDF
Research Article Oncology Article has an altmetric score of 17

Severe consequences of a high-lipid diet include hydrogen sulfide dysfunction and enhanced aggression in glioblastoma

  • Text
  • PDF
Abstract

Glioblastoma (GBM) remains among the deadliest of human malignancies, and the emergence of the cancer stem cell (CSC) phenotype represents a major challenge to durable treatment response. Because the environmental and lifestyle factors that impact CSC populations are not clear, we sought to understand the consequences of diet on CSC enrichment. We evaluated disease progression in mice fed an obesity-inducing high-fat diet (HFD) versus a low-fat, control diet. HFD resulted in hyperaggressive disease accompanied by CSC enrichment and shortened survival. HFD drove intracerebral accumulation of saturated fats, which inhibited the production of the cysteine metabolite and gasotransmitter, hydrogen sulfide (H2S). H2S functions principally through protein S-sulfhydration and regulates multiple programs, including bioenergetics and metabolism. Inhibition of H2S increased proliferation and chemotherapy resistance, whereas treatment with H2S donors led to death of cultured GBM cells and stasis of GBM tumors in vivo. Syngeneic GBM models and GBM patient specimens present an overall reduction in protein S-sulfhydration, primarily associated with proteins regulating cellular metabolism. These findings provide clear evidence that diet-modifiable H2S signaling serves to suppress GBM by restricting metabolic fitness, while its loss triggers CSC enrichment and disease acceleration. Interventions augmenting H2S bioavailability concurrent with GBM standard of care may improve outcomes for patients with GBM.

Authors

Daniel J. Silver, Gustavo A. Roversi, Nazmin Bithi, Sabrina Z. Wang, Katie M. Troike, Chase K.A. Neumann, Grace K. Ahuja, Ofer Reizes, J. Mark Brown, Christopher Hine, Justin D. Lathia

×

Total citations by year

Year: 2024 2023 2022 2021 Total
Citations: 9 4 8 4 25
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (25)

Title and authors Publication Year
Multi-omic screening of invasive GBM cells in engineered biomaterials and patient biopsies reveals targetable transsulfuration pathway alterations
Joseph Garcia, Erin Akins, Saket Jain, Kayla Wolf, Jason Zhang, Nikita Choudhary, Meeki Lad, Poojan Shukla, Sabraj Gill, Will Carson, Luis Carrete, Allison Zheng, Sanjay Kumar, Manish Aghi
Journal of Clinical Investigation 2024
Should I stay or should I go: Transsulfuration influences invasion and growth in glioblastoma
Justin Lathia
Journal of Clinical Investigation 2024
Cysteine induces mitochondrial reductive stress in glioblastoma through hydrogen peroxide production.
Noch EK, Palma L, Yim I, Bullen N, Barnett D, Walsh A, Bhinder B, Benedetti E, Krumsiek J, Gurvitch J, Khwaja S, Atlas D, Elemento O, Cantley LC
Proceedings of the National Academy of Sciences 2024
The Lipidomic Signature of Glioblastoma: A Promising Frontier in Cancer Research.
Yu N, Aboud O
Cancers 2024
Mutations in the TP53, VEGFA, and CTH Genes as Key Molecular Markers for the Diagnosis of Glioblastoma
Khalil SS, Salihi A
Cureus 2024
Cystathionine-γ-lyase contributes to tamoxifen resistance, and the compound I194496 alleviates this effect by inhibiting the PPARγ/ACSL1/STAT3 signalling pathway in oestrogen receptor-positive breast cancer.
Fu H, Han X, Guo W, Zhao X, Yu C, Zhao W, Feng S, Wang J, Zhang Z, Lei K, Li M, Wang T
Scientific reports 2024
Metabolism: an important player in glioma survival and development
Wang N, Yuan Y, Hu T, Xu H, Piao H
Discover Oncology 2024
CB2R activation enhances tumor-associated macrophages-mediated phagocytosis of glioma cell
Lu S, Chen X, Yang Y, Li J
Heliyon 2024
Diet-Modifiable Redox Alterations in Ageing and Cancer
Hine C, Patel AK, Ponti A
Sub-cellular biochemistry 2024
Targeting fatty acid metabolism in glioblastoma
Jason Miska1* and Navdeep Chandel2
Journal of Clinical Investigation 2023
Fatty Acid Metabolites and the Tumor Microenvironment as Potent Regulators of Cancer Stem Cell Signaling
Murai T, Matsuda S
Metabolites 2023
Cystathionine gamma-lyase (CTH) inhibition attenuates glioblastoma formation.
Peleli M, Antoniadou I, Rodrigues-Junior DM, Savvoulidou O, Caja L, Katsouda A, Ketelhuth DFJ, Stubbe J, Madsen K, Moustakas A, Papapetropoulos A
Redox Biology 2023
Homeostatic iron regulatory protein drives glioblastoma growth via tumor cell-intrinsic and sex-specific responses.
Troike KM, Wang SZ, Silver DJ, Lee J, Mulkearns-Hubert EE, Hajdari N, Ghosh PK, Kay KE, Beilis JL, Mitchell SE, Bishop CW, Hong ES, Artomov M, Hubert CG, Rajappa P, Connor JR, Fox PL, Kristensen BW, Lathia JD
2023
Emerging roles of cystathionine β-synthase in various forms of cancer
Ascenção K, Szabo C
Redox Biology 2022
The complex interactions between the cellular and non-cellular components of the brain tumor microenvironmental landscape and their therapeutic implications
Faisal SM, Comba A, Varela ML, Argento AE, Brumley E, Abel C II, Castro MG, Lowenstein PR
Frontiers in Oncology 2022
Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS
Weller J, Schäfer N, Schaub C, Potthoff AL, Steinbach JP, Schlegel U, Sabel M, Hau P, Seidel C, Krex D, Goldbrunner R, Pietsch T, Tzaridis T, Zeyen T, Borger V, Güresir E, Vatter H, Herrlinger U, Schneider M
Journal of Neuro-Oncology 2022
Role of Diet in Stem and Cancer Stem Cells
Puca F, Fedele M, Rasio D, Battista S
International journal of molecular sciences 2022
Heterogeneity of glioblastoma stem cells in the context of the immune microenvironment and geospatial organization
Silver A, Feier D, Ghosh T, Rahman M, Huang J, Sarkisian MR, Deleyrolle LP
Frontiers in Oncology 2022
Glioblastoma cell motility depends on enhanced oxidative stress coupled with mobilization of a sulfurtransferase.
Saurty-Seerunghen MS, Daubon T, Bellenger L, Delaunay V, Castro G, Guyon J, Rezk A, Fabrega S, Idbaih A, Almairac F, Burel-Vandenbos F, Turchi L, Duplus E, Virolle T, Peyrin JM, Antoniewski C, Chneiweiss H, El-Habr EA, Junier MP
Cell Death and Disease 2022
The Role of Hydrogen Sulfide in the Development and Progression of Lung Cancer.
Yang YL, Zhang K, Zhou ZT, Jiang ZL, Liu Y, Zhang YX, Liu ZH, Ji XY, Wu DD
Molecules (Basel, Switzerland) 2022
Endometriosis Stem Cells as a Possible Main Target for Carcinogenesis of Endometriosis-Associated Ovarian Cancer (EAOC)
Wilczyński JR, Szubert M, Paradowska E, Wilczyński M
Cancers 2022
PD-1 independent of PD-L1 ligation promotes glioblastoma growth through the NFκB pathway
R Mirzaei, A Gordon, FJ Zemp, M Kumar, S Sarkar, HA Luchman, AC Bellail, C Hao, DJ Mahoney, JF Dunn, P Bose, VW Yong
Science Advances 2021
Hydrogen sulfide operates as a glioblastoma suppressor and is lost under high fat diet
DJ Silver, JD Lathia, C Hine
Molecular & Cellular Oncology 2021
Early DNA damage detection and cellular autophagy as drivers of stress-adaptive H2S production: A paradox resolved
C Hine, D Wainwright, J Lathia
Cell Chemical Biology 2021
The CBS-H2S axis promotes liver metastasis of colon cancer by upregulating VEGF through AP-1 activation
S Guo, J Li, Z Huang, T Yue, J Zhu, X Wang, Y Liu, P Wang, S Chen
British Journal of Cancer 2021

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 30 X users
50 readers on Mendeley
See more details